EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mucosal immune responses in COVID19 - a living review

Claire F Pearson, Rebecca Jeffery, Oxford-Cardiff COVID-19 Literature Consortium, Emily E Thornton iD

Oxford Open Immunology · 2021

DOI: 10.1093/oxfimm/iqab002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oxford Open Immunology, 2021. Verfasst von Claire F Pearson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Kennedy Institute of Rheumatology, NDORMS, University of Oxford, Roosevelt Drive, Oxford OX3 7FY, UK. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, Nuffield Department of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

COVID-19 was initially characterized as a disease primarily of the lungs, but it is becoming increasingly clear that the SARS-CoV2 virus is able to infect many organs and cause a broad pathological response. The primary infection site is likely to be a mucosal surface, mainly the lungs or the intestine, where epithelial cells can be infected with virus. Although it is clear that virus within the lungs can cause severe pathology, driven by an exaggerated immune response, infection within the intestine generally seems to cause minor or no symptoms. In this review, we compare the disease processes between the lungs and gastrointestinal tract, and what might drive these different responses. As the microbiome is a key part of mucosal barrier sites, we also consider the effect that microbial species may play on infection and the subsequent immune responses. Because of difficulties obtaining tissue samples, there are currently few studies focused on the local mucosal response rather than the systemic response, but understanding the local immune response will become increasingly important for understanding the mechanisms of disease in order to develop better treatments.

Schlagwörter

Stichwörter der Autor:innen

COVID-19gutlungmicrobiomemucosal immunity

Autor:innen und Institutionen

  • Kennedy Institute of Rheumatology, NDORMS, University of Oxford, Roosevelt Drive, Oxford OX3 7FY, UK.

ORCID-Profile: Emily E Thornton

Förderung

  • Wellcome Trust
  • Medical Research Council
  • Nuffield Department of Medicine
  • University of Oxford

Zitieren

APA

Pearson, C. F., Jeffery, R., Oxford-Cardiff COVID-19 Literature Consortium, & Thornton, E. E. (2021). Mucosal immune responses in COVID19 - a living review. Oxford Open Immunology. https://doi.org/10.1093/oxfimm/iqab002

Vancouver

Pearson CF, Jeffery R, Oxford-Cardiff COVID-19 Literature Consortium, Thornton EE. Mucosal immune responses in COVID19 - a living review. Oxford Open Immunology. 2021. doi:10.1093/oxfimm/iqab002

BibTeX
@article{Pearson2021,
  author = {Pearson, Claire F and Jeffery, Rebecca and Oxford-Cardiff COVID-19 Literature Consortium, Oxford-Cardiff COVID-19 Literature Consortium and Thornton, Emily E},
  title = {Mucosal immune responses in COVID19 - a living review},
  journal = {Oxford Open Immunology},
  year = {2021},
  doi = {10.1093/oxfimm/iqab002}
}
Kostenlos starten →